Tag: John Figueroa
Apria positioned for 'added scale'
May 3, 2013Theresa Flaherty, Managing Editor
LAKE FOREST, Calif. - Execs at Apria Healthcare say the company is well-positioned going into Round 2 of competitive bidding.Apria has confirmed to HME News that it has accepted 371 contracts under Round 2, mainly in its core business lines of oxygen, CPAP and enteral nutrition, as well as a “significant number” of contracts for negative pressure wound therapy (NPWT).“Our clinical expertise, coupled with our national platform, makes us well-positioned to take on added scale, while...
Apria bullish on success under bid program
March 15, 2013Theresa Flaherty, Managing Editor
LAKE FOREST, Calif. - Execs at Apria Healthcare revealed during an earnings call March 11 that the company was offered “a significant number of contracts” for Round 2 of competitive bidding.
CEO John Figueroa said that, like in Round 1, Apria was offered contracts in oxygen, CPAP, enteral nutrition and a few “non-core” products. For Round 2, it was also offered contracts for negative pressure wound therapy.
“We are pleased with the outcome despite the average 45%...
In brief: Apria taps new CEO, C&C Homecare buys Allcare
November 30, 2012HME News Staff
LAKE FOREST, Calif. - Apria Healthcare has named John Figueroa as its new CEO and chairman of its board of directors, according to a press release. Figueroa will also assume the position of CEO for Apria's Coram home infusion unit. Figueroa most recently served as CEO and board member of Cincinnati-based Omnicare, a pharmaceutical company. He will succeed Norman Payson, MD, who recently announced his intention to retire. Payson will continue to provide Apria with counsel as senior adviser and...
Apria taps new CEO
November 30, 2012HME News Staff
LAKE FOREST, Calif. - Apria Healthcare has named John Figueroa as its new CEO and chairman of its board of directors, according to a press release. Figueroa will also assume the position of CEO for Apria's Coram home infusion unit. Figueroa most recently served as CEO and board member of Cincinnati-based Omnicare, a pharmaceutical company. He will succeed Norman Payson, MD, who recently announced his intention to retire. Payson will continue to provide Apria with counsel as senior adviser and as...